PO.CL05.10 · 临床研究

胰腺癌中一种新型lncRNA的鉴定:通过Wnt通路调控促进恶性进展

Identification of a novel lncRNA in pancreatic cancer: Contribution to malignancy through Wnt pathway regulation

海报缩略图:胰腺癌中一种新型lncRNA的鉴定:通过Wnt通路调控促进恶性进展
编号 7938 展板 13 时间 4/22 09:00–12:00 区域 Section 49 主讲 Isshin NARUMOTO, No Degree
分会场 Tumor Microenvironment Modulators
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Isshin Narumoto, Keiko Shinjo, Yutaka Kondo, Shu Hirako

Nagoya University, Nagoya, Japan

摘要 Abstract

中文摘要
长链非编码RNA(lncRNA)是长度超过200个核苷酸的非编码RNA,通过与多种蛋白质相互作用,在转录调控和蛋白质定位中发挥重要作用。这些功能在癌症研究中引起了广泛关注。 我们鉴定出lnc243,其在胰腺导管腺癌(PDAC)的间充质型细胞中高表达,并与患者预后不良相关。既往研究报道,lnc243通过结合miRNA作为竞争性内源RNA来调控mRNA表达。然而,lnc243在PDAC中的亚细胞定位及其通过蛋白质相互作用发挥的功能仍知之甚少。RNA荧光原位杂交(RNA-FISH)显示,lnc243的定位随细胞状态而变化:在贴壁细胞中定位于细胞膜,但在侵袭过程中转移至细胞质。由于发现lnc243与beta-catenin在细胞膜上共定位,我们随后使用AlphaFold3检验了二者潜在的相互作用。该分析提示lnc243与beta-catenin之间可能存在相互作用,RNA免疫沉淀进一步支持了这一点,显示beta-catenin与lnc243结合。此外,敲低lnc243导致beta-catenin翻译后水平下降。 Wnt通路基因突变在PDAC中较为罕见;然而,lnc243表达升高可能代表一种失调beta-catenin并促进PDAC恶性进展的替代机制。
查看英文原文 English abstract
Long non-coding RNAs (lncRNAs) are non-coding RNAs longer than 200 nucleotides that play essential roles in transcriptional regulation and protein localization through interactions with various proteins. These functions have attracted considerable attention in cancer research. We identified lnc243, which is highly expressed in mesenchymal-type cells of pancreatic ductal adenocarcinoma (PDAC) and is associated with poor patient survival. Previous studies reported that lnc243 regulates mRNA expression by acting as a competing endogenous RNA through binding to miRNAs. However, the subcellular localization of lnc243 and its function through protein interactions in PDAC remain poorly understood.RNA fluorescence in situ hybridization (RNA-FISH) revealed that lnc243 localization varies depending on the cellular state: it is localized to the cell membrane in adherent cells but translocates into the cytoplasm during invasion. Because lnc243 and beta-catenin were found to co-localize on the cell membrane, we next examined their potential interaction using AlphaFold3. This analysis suggested a possible interaction between lnc243 and beta-catenin, which was further supported by RNA immunoprecipitation showing that beta-catenin binds to lnc243. Moreover, knockdown of lnc243 led to a decrease in the post-translational levels of beta-catenin. Mutations in Wnt pathway genes are rare in PDAC; however, increased lnc243 expression may represent an alternative mechanism for dysregulating beta-catenin and promoting malignancy in PDAC.
利益披露 Disclosure
I. Narumoto, None.. Y. Kondo, None.

← 返回 AACR 2026 检索